Skip to menu Skip to content Skip to footer
Professor Alexander Khromykh
Professor

Alexander Khromykh

Email: 
Phone: 
+61 7 334 67219

Overview

Background

Alexander Khromykh has PhD degree in Molecular Virology. He worked as Postdoctoral Fellow at the University of Ottawa in Canada. He then joined Sir Albert Sakzewski Virus Research Centre in Brisbane and became a laboratory Head in 2001. He moved his laboratory to St Luica campus in 2005 to take an appointment with the School of Chemistry and Molecular Biosciences (SCMB). He was the founding Director of the SCMB’s Centre for Infectious Disease Research and is currently the Deputy Director of the Australian Infectious Diseases Research Centre. He is also the Director of Centre of Excellence and a member of COVID-19 and Zika virus Task Forces in the Global Virus Network.

Availability

Professor Alexander Khromykh is:
Available for supervision
Media expert

Qualifications

  • Bachelor of Science, Tomsk State University
  • Doctor of Philosophy, The Institute for Molecular Virology

Research interests

  • Molecular pathogenesis of RNA viruses

    Viruses of main interest include West Nile virus, Zika virus and SARS-CoV-2 virus. A particular strength is in the developing infectious clones and replicons and utilising them to study virus replication, to identify viral determinants of pathogenicity and to develop vaccines and antivirals.

  • Evasion of host antiviral response by pathogenic RNA viruses

    We apply advanced molecular methodologies including screening with viral RNAi libraries to identify new host antiviral genes and to dissect mechanisms employed by pathogenic RNA viruses to evade antiviral responses.

  • The role of viral and host noncoding RNAs in virus-host interaction

    We study biogenesis of novel viral noncoding RNAs and elucidate mechanisms by which both, viral and host noncoding RNAs shape the outcomes of infection with pathogenic RNA viruses.

Research impacts

The main areas of research of the group are molecular virology, viral pathogenesis, and virus-host interactions. The viruses studied in the group are pathogenic RNA viruses, viruses such as West Nile virus, Zika virus, and SARS-CoV-2 virus. The goal of the research is to determine the mechanisms by which these viruses cause disease in the hosts and to identify viral and host factors determining the outcome of infection. The group uses a range of classical and more modern approaches including molecular manipulations with viral infectious cDNA clones and replicons, transient and stable expression of viral proteins and noncoding RNAs, viral replication and virulence assays, deep mutational scanning, mass spectrometry, next generation sequencing, siRNA knockdowns, and knockout cells and mice. Together, these approaches allow the group to perform detailed analysis of the effects of changes in the viral and host genomes that are likely to have a profound impact on virus replication and pathogenesis. The obtained knowldge is also applied to develop novel vaccine platforms and test antivirals.

Works

Search Professor Alexander Khromykh’s works on UQ eSpace

216 works between 1990 and 2025

101 - 120 of 216 works

2012

Journal Article

A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability

Moon, Stephanie L., Anderson, John R., Kumagai, Yutaro, Wilusz, Carol J., Akira, Shizuo, Khromykh, Alexander A. and Wilusz, Jeffrey (2012). A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability. RNA, 18 (11), 2029-2040. doi: 10.1261/rna.034330.112

A noncoding RNA produced by arthropod-borne flaviviruses inhibits the cellular exoribonuclease XRN1 and alters host mRNA stability

2012

Journal Article

Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock

Rudd, Penny A., Wilson, Jane, Gardner, Joy, Larcher, Thibaut, Babarit, Candice, Le, Thuy T., Anraku, Itaru, Kumagai, Yutaro, Loo, Yueh-Ming, Gale Jr, Michael, Akira, Shizuo, Khromykh, Alexander A. and Suhrbier, Andreas (2012). Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock. Journal of Virology, 86 (18), 9888-9898. doi: 10.1128/JVI.00956-12

Interferon response factors 3 and 7 protect against Chikungunya virus hemorrhagic fever and shock

2012

Journal Article

Identification of residues in West Nile virus premembrane protein that influence viral particle secretion and virulence

Setoh, Y. X., Prow, N. A., Hobson-Peters, J., Lobigs, M., Young, P. R., Khromykh, A. A. and Hall, R. A. (2012). Identification of residues in West Nile virus premembrane protein that influence viral particle secretion and virulence. Journal of General Virology, 93 (Part 9), 1965-1975. doi: 10.1099/vir.0.044453-0

Identification of residues in West Nile virus premembrane protein that influence viral particle secretion and virulence

2012

Journal Article

West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response

Schuessler, Andrea, Funk, Anneke, Lazear, Helen M., Cooper, Daphne A., Torres, Shessy, Daffis, Stephane, Jha, Babal Kant, Kumagai, Yutaro, Takeuchi, Osamu, Hertzog, Paul, Silverman, Robert, Akira, Shizuo, Barton, David J., Diamond, Michael S. and Khromykh, Alexander A. (2012). West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response. Journal of Virology, 86 (10), 5708-5718. doi: 10.1128/JVI.00207-12

West Nile virus noncoding subgenomic RNA contributes to viral evasion of the type I interferon-mediated antiviral response

2012

Journal Article

Characterization of virulent West Nile virus Kunjin Strain, Australia, 2011

Frost, Melinda J., Zhang, Jing, Edmonds, Judith H., Prow, Natalie A., Gu, Xingnian, Davis, Rodney, Hornitzky, Christine, Arzey, Kathleen E., Finlaison, Deborah, Hick, Paul, Read, Andrew, Hobson-Peters, Jody, May, Fiona J., Doggett, Stephen L., Haniotis, John, Russell, Richard C., Hall, Roy A., Khromykh, Alexander A. and Kirkland, Peter D. (2012). Characterization of virulent West Nile virus Kunjin Strain, Australia, 2011. Emerging Infectious Diseases, 18 (5), 792-800. doi: 10.3201/eid1805.111720

Characterization of virulent West Nile virus Kunjin Strain, Australia, 2011

2012

Journal Article

West Nile virus encodes a microRNA-like small RNA in the 3' untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells

Hussain, Mazhar, Torres, Shessy, Schnettler, Esther, Funk, Anneke, Grundhoff, Adam, Pijlman, Gorben P., Khromykh, Alexander A. and Asgari, Sassan (2012). West Nile virus encodes a microRNA-like small RNA in the 3' untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells. Nucleic Acids Research, 40 (5), 2210-2223. doi: 10.1093/nar/gkr848

West Nile virus encodes a microRNA-like small RNA in the 3' untranslated region which up-regulates GATA4 mRNA and facilitates virus replication in mosquito cells

2012

Book Chapter

Flavivirus replication and assembly

Roby, Justin A., Funk, Anneke and Khromykh, Alexander A. (2012). Flavivirus replication and assembly. Molecular virology and control of flaviviruses. (pp. 21-49) edited by Pei-Yong Shi. Norfolk, United Kingdom: Caister Academic Press.

Flavivirus replication and assembly

2011

Journal Article

Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection

Reynard, O., Mokhonov, V., Mokhonova, E., Leung, J., Page, A., Mateo, M., Pyankova, O., Georges-Courbot, M. C., Raoul, H., Khromykh, A. A. and Volchkov, V. E. (2011). Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection. Journal of Infectious Diseases, 204 (3), S1060-S1065. doi: 10.1093/infdis/jir347

Kunjin virus replicon-based vaccines expressing Ebola virus glycoprotein GP protect the guinea pig against lethal Ebola virus infection

2011

Journal Article

Determinants of attenuation in the envelope protein of the flavivirus Alfuy

Prow, Natalie A., May, Fiona J., Westlake, Daniel J., Hurrelbrink, Robert J., Biron, Rebecca M., Leung, Jason Y., McMinn, Peter C., Clark, David C., Mackenzie, John S., Lobigs, Mario, Khromykh, Alexander A. and Hall, Roy A. (2011). Determinants of attenuation in the envelope protein of the flavivirus Alfuy. Journal of General Virology, 92 (10), 2286-2296. doi: 10.1099/vir.0.034793-0

Determinants of attenuation in the envelope protein of the flavivirus Alfuy

2011

Journal Article

pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects

Faham, Abdus, Herringson, Thomas, Parish, Chris, Suhrbier, AandreaS, Khromykh, Alexander A. and Altin, Joseph G. (2011). pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects. Vaccine, 29 (40), 6911-6919. doi: 10.1016/j.vaccine.2011.07.045

pDNA-lipoplexes engrafted with flagellin-related peptide induce potent immunity and anti-tumour effects

2011

Journal Article

The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response

Daffis, Stephane, Lazear, Helen M., Liu, Wen Jun, Audsley, Michelle, Engle, Michael, Khromykh, Alexander A. and Diamond, Michael S. (2011). The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response. Journal of Virology, 85 (11), 5664-5668. doi: 10.1128/JVI.00232-11

The naturally attenuated Kunjin strain of West Nile virus shows enhanced sensitivity to the host type I interferon response

2011

Journal Article

Virulence determinants between New York 99 and Kunjin strains of West Nile virus

Audsley, Michelle, Edmonds, Judith, Liu, Wenjun, Mokhonov, Vlad, Mokhonova, Ekaterina, Melian, Ezequeil Balmori, Prow, Natalie, Hall, Roy A. and Khromykh, Alexander A. (2011). Virulence determinants between New York 99 and Kunjin strains of West Nile virus. Virology, 414 (1), 63-73. doi: 10.1016/j.virol.2011.03.008

Virulence determinants between New York 99 and Kunjin strains of West Nile virus

2011

Book Chapter

Nucleic acid-based infectious and pseudoinfectious flavivirus vaccines

Roby, Justin A., Hall, Roy A. and Khromykh, Alexander A. (2011). Nucleic acid-based infectious and pseudoinfectious flavivirus vaccines. Replicating vaccines : A new generation. (pp. 299-320) edited by Philip R. Dormitzer, Christian W. Mandl and Rino Rappuoli. Basel, Switzerland: Springer. doi: 10.1007/978-3-0346-0277-8_13

Nucleic acid-based infectious and pseudoinfectious flavivirus vaccines

2011

Journal Article

Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: An ELISPOT analysis

Rattanasena, Paweena, Anraku, Itaru, Gardner, Joy, Le, Thuy T., Wang, Xiang Ju, Khromykh, Alexander A. and Suhrbier, Andreas (2011). Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: An ELISPOT analysis. Immunology and Cell Biology, 89 (3), 426-436. doi: 10.1038/icb.2010.99

Prime-boost vaccinations using recombinant flavivirus replicon and vaccinia virus vaccines: An ELISPOT analysis

2010

Journal Article

RNA structures required for production of subgenomic flavivirus RNA

Funk, Anneke, Truong, Katherine, Nagasaki, Tomoko, Torres, Shessy, Floden, Nadia, Balmori Melian, Ezequiel, Edmonds, Judy, Dong, Hongping, Shi, Pei-Yong and Khromykh, Alexander A. (2010). RNA structures required for production of subgenomic flavivirus RNA. Journal of Virology, 84 (21), 11407-11417. doi: 10.1128/JVI.01159-10

RNA structures required for production of subgenomic flavivirus RNA

2010

Journal Article

Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling

Fros, Jelke J., Liu, Wen Jun, Prow, Natalie A., Geertsema, Corinne, Ligtenberg, Maarten, Vanlandingham, Dana L., Schnettler, Esther, Vlak, Just M., Suhrbier, Andreas, Khromykh, Alexander A. and Pijlman, Gorben P. (2010). Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling. Journal of Virology, 84 (20), 10877-10887. doi: 10.1128/JVI.00949-10

Chikungunya virus nonstructural protein 2 inhibits type I/II interferon-stimulated JAK-STAT signaling

2010

Journal Article

Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice

Prow, Tarl W., Chen, Xianfeng, Prow, Natalie A., Fernando, Germain J. P., Tan, Cindy S. E., Raphael, Anthony P., Chang, David, Ruutu, Merja P., Jenkins, Derek W. K., Pyke, Alyssa, Crichton, Michael L., Raphaelli, Kristin, Goh, Lucas Y. H., Frazer, Ian H., Roberts, Michael S., Gardner, Joy, Khromykh, Alexander A., Suhrbier, Andreas, Hall, Roy A. and Kendall, Mark A. F. (2010). Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice. Small, 6 (16), 1776-1784. doi: 10.1002/smll.201000331

Nanopatch-targeted skin vaccination against West Nile virus and chikungunya virus in mice

2010

Journal Article

The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling

Laurent-Rolle, Maudry, Boer, Elena F., Lubick, Kirk J., Wolfinbarger, James B., Carmody, Aaron B., Rockx, Barry, Liu, Wenjun, Ashour, Joseph, Shupert, W. Lesley, Holbrook, Michael R., Barrett, Alan D., Mason, Peter W., Bloom, Marshall E., Garcia-Sastre, Adolfo, Khromykh, Alexander A. and Best, Sonja M. (2010). The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling. Journal of Virology, 84 (7), 3503-3515. doi: 10.1128/JVI.01161-09

The NS5 protein of the virulent West Nile virus NY99 strain is a potent antagonist of type I interferon-mediated JAK-STAT signaling

2010

Journal Article

Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b

Mertens, E, Kajaste-Rudnitski, A, Torres, S, Funk, A, Frenkiel, MP, Iteman, I, Khromykh, AA and Despres, P (2010). Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b. Virology, 399 (1), 176-185. doi: 10.1016/j.virol.2009.12.036

Viral determinants in the NS3 helicase and 2K peptide that promote West Nile virus resistance to antiviral action of 2′,5′-oligoadenylate synthetase 1b

2010

Journal Article

NS1 ' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness

Balmori Melian, Ezequiel, Hinzman, Edward, Nagasaki, Tomoko, Firth, Andrew E., Wills, Norma M., Nouwens, Amanda S., Blitvich, Bradley J., Leung, Jason, Funk, Anneke, Atkins, John F., Hall, Roy and Khromykh, Alexander A. (2010). NS1 ' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness. Journal of Virology, 84 (3), 1641-1647. doi: 10.1128/JVI.01979-09

NS1 ' of flaviviruses in the Japanese encephalitis virus serogroup is a product of ribosomal frameshifting and plays a role in viral neuroinvasiveness

Funding

Current funding

  • 2025 - 2028
    Lost in translation: why flaviviruses induce cleavage of tRNAs
    NHMRC IDEAS Grants
    Open grant
  • 2024 - 2027
    From shape to function: how structured RNA defines insect flaviviruses
    ARC Discovery Projects
    Open grant
  • 2022 - 2025
    Predicting and preparing for the unfolding evolution of SARS-CoV-2
    NHMRC IDEAS Grants
    Open grant

Past funding

  • 2022 - 2024
    How the synergy between flavivirus protein and noncoding RNA defeats antiviral response
    NHMRC IDEAS Grants
    Open grant
  • 2020 - 2023
    Chimeric insect-specific viruses as novel vaccines for mosquito-borne diseases
    NHMRC Development Grant
    Open grant
  • 2019 - 2023
    Noncoding RNAs of insect-specific flaviviruses: biogenesis and functions
    ARC Discovery Projects
    Open grant
  • 2018 - 2020
    Chimeric insect-specific flaviviruses: a new generation of diagnostics and vaccines against mosquito-borne viral disease
    NHMRC Project Grant
    Open grant
  • 2018
    Epifluorescent and live-cell imaging microscopes for the investigation of host-pathogen interactions and for molecular and cellular biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2018 - 2021
    Viral and host factors determining outcome of Zika virus infection
    NHMRC Project Grant
    Open grant
  • 2017 - 2019
    The role of non-coding viral RNAs in flavivirus infection and exosomal signalling
    NHMRC Project Grant
    Open grant
  • 2016 - 2018
    Host genes controlling Flavivirus infection: new insights and application for developing highly effective Kunjin replicon-based Ebola vaccine
    NHMRC Project Grant
    Open grant
  • 2016
    Instrumentation for the analysis of cellular and metabolic phenotypes
    UQ Major Equipment and Infrastructure
    Open grant
  • 2015
    A sensitive, high resolution QTOF mass spectrometer with nanoUPLC system for qualitative and quantitative biomolecule analysis.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014
    A confocal microscope for investigation of live bacterial and viral pathogens and for molecular cell biology
    UQ Major Equipment and Infrastructure
    Open grant
  • 2014 - 2019
    NHMRC Research Fellowship (SRFB): Pathogenic flaviviruses: molecular mechanisms of disease, host response and vaccines
    NHMRC Research Fellowship
    Open grant
  • 2014 - 2016
    Wolbachia and West Nile virus in mosquitoes: friends or foes?
    NHMRC Project Grant
    Open grant
  • 2013 - 2014
    Kunjin virus replicon vector plasmid evaluation
    UniQuest Pty Ltd
    Open grant
  • 2013 - 2015
    Molecular pathogenesis of emerging West Nile viruses
    NHMRC Project Grant
    Open grant
  • 2013 - 2015
    The role of noncoding subgenomic flavivirus RNA in virus-host interactions
    NHMRC Project Grant
    Open grant
  • 2012 - 2015
    Emergence of a virulent strain of West Nile virus causing fatal equine encephalitis in South Eastern Australia
    ARC Linkage Projects
    Open grant
  • 2012 - 2014
    Do insect-specific flaviviruses regulate the transmission of mosquito-borne diseases in Australia?
    ARC Discovery Projects
    Open grant
  • 2012 - 2014
    Role of flavivirus-encoded small regulatory RNAs in virus-mosquito vector interactions
    NHMRC Project Grant
    Open grant
  • 2011
    Cell culture facilities for studying host-pathogen interactions and immune function
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011
    Mass spectrometer for biomolecule discovery, structural analysis and quantification.
    UQ Major Equipment and Infrastructure
    Open grant
  • 2011 - 2013
    Regulatory cellular microRNAs and their role in insect anti-viral responses
    ARC Discovery Projects
    Open grant
  • 2011 - 2013
    Viral factors contributing to flavivirus-induced cell death and pathogenicity
    NHMRC Project Grant
    Open grant
  • 2010 - 2012
    A functional interaction between domains of the flavivirus NS5 protein presents a new target for antiviral therapy
    NHMRC Project Grant
    Open grant
  • 2010
    An integrated high -throughput fluorescence imaging facility
    UQ Major Equipment and Infrastructure
    Open grant
  • 2010 - 2013
    Inhibition of interferon-alpah/beta by chikungunya virus and the induction of arthritis (NHMRC Project grant administered by QIMR)
    Queensland Institute of Medical Research
    Open grant
  • 2010 - 2013
    The role of subgenomic non-coding viral RNA in flavivirus pathogenicity
    NHMRC Project Grant
    Open grant
  • 2009 - 2012
    Detection of imported exotic strains of West Nile virus for national biosecurity surveillance.
    ARC Discovery Projects
    Open grant
  • 2009 - 2011
    Development of technique for rapid detection of pathogenic airborne particles (Australian Government co-funding research project led by Griffith University)
    Griffith University
    Open grant
  • 2009
    Infrastructure for biochemistry and infectious disease resarch in molecualr biosciences
    UQ School/Centre Co-Funding
    Open grant
  • 2009 - 2013
    NHMRC Research Fellowship (SRFA): Flavivirus replication
    NHMRC Research Fellowship
    Open grant
  • 2008
    Molecular Epidemiology and pathogenesis of mosquito-borne viruses
    NHMRC Equipment Grant
    Open grant
  • 2008 - 2010
    West Nile virus replication and host response
    NHMRC Project Grant
    Open grant
  • 2007 - 2008
    Development of technique for rapid detection of pathogenic ariborne particles (PR06-0054)
    Griffith University
    Open grant
  • 2007 - 2009
    Development of strategies for early detection of respiratory microbial infections possibly imported to Australia by humans and animals
    Griffith University
    Open grant
  • 2007 - 2009
    Inhibitors Of West Nile Virus Protease As Antiviral Drugs
    NHMRC Project Grant
    Open grant
  • 2007 - 2010
    Viral factors involved in flavivirus replication and virus-host interactions
    NHMRC Project Grant
    Open grant
  • 2007 - 2010
    Virulence determinants of encephalitic flaviviruses
    NHMRC Project Grant
    Open grant
  • 2005 - 2010
    Attenuated West Nile virus vaccine
    United States National Institutes of Health
    Open grant
  • 2005 - 2008
    Cellular microenvironments facilitating the replication and propagation of flaviviruses
    NHMRC Project Grant
    Open grant
  • 2005 - 2008
    How do flaviviruses modulate interferon response
    NHMRC Project Grant
    Open grant
  • 2005
    NHMRC_Equipment Grant = Three Class II Biohazard cabinets and one -86OC Freezer
    NHMRC Equipment Grant
    Open grant
  • 2005
    The West Nile viral protease NS3: a target for antiviral drug and vaccine design
    NHMRC Project Grant
    Open grant
  • 2004 - 2005
    A Hybrid Fowlpox-Kunjin virus vector for the delivery of HIV/AIDS vaccines
    CSIRO
    Open grant
  • 2004 - 2007
    Flavivirus RNA replication and virus assembly
    NHMRC Project Grant
    Open grant
  • 2004 - 2005
    Induction of protective immune responses to SIV Gag by Kunjin replicon vaccine in non-human primates
    University of Melbourne
    Open grant
  • 2004 - 2008
    NHMRC Senior Research Fellowship
    NHMRC Research Fellowship
    Open grant
  • 2003 - 2006
    Development of a personal sampler for viable airborne bacteria, fungi and virus
    Griffith University
    Open grant
  • 2003 - 2007
    Development of Kunjin replicon-based Ebola vaccine
    United States National Institutes of Health
    Open grant
  • 2003 - 2005
    New system for gene therapy and protein production
    Queensland Institute of Medical Research
    Open grant
  • 2003 - 2004
    Novel polytope VLP vaccines for respiratory syncytial virus (RSV) infection in children
    Royal Children's Hospital Foundation
    Open grant
  • 2001 - 2003
    Molecular analyses of Favivirus RNA Replication, Packaging and Complementation
    NHMRC Project Grant
    Open grant
  • 2000 - 2003
    Kunjin virus replicon as a vector for HIV vaccine
    United States National Institutes of Health
    Open grant
  • 2000 - 2002
    Flavivirus replication - Biogenesis, ultrastructure and functions of induced membranes.
    NHMRC Project Grant
    Open grant

Supervision

Availability

Professor Alexander Khromykh is:
Available for supervision

Before you email them, read our advice on how to contact a supervisor.

Available projects

  • Cooperation between sfRNA and non-structural protein NS5 for flavivirus immune evasion

    This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.

    Flaviviruses are important human pathogens that include West Nile, Dengue, Zika, Yellow fever virus and other viruses. They have a unique ability to produce viral noncoding RNA from their 3' untranslated region by hijacking host exoribonuclease. This RNA, termed subgenomic flaviviral RNA (sfRNA), accumulates in infected cells in high abundance and facilitates viral pathogenesis by supressing antiviral response. However, the molecular mechanism that determines this activity is not fully elucidated. Recently we have discovered that sfRNA of Zika virus executes this function in cooperation with the viral protein NS5. We found that sfRNA binds to and stabilises NS5, allowing this protein to inhibit phosphorylation of transcriptional factor STAT1, a key mediator of antiviral signalling.

    This project is aimed to uncover how sfRNA binding effects NS5 conformation and its ability to inhibit STAT1 phosphorylation by identifying interacting sites in both molecules, characterising structural changes in NS5 caused by sfRNA binding and creating mutant viruses incapable of sfRNA-NS5 interactions. It will also investigate whether this mechanism is conserved between all flaviviruses.

    The successful candidate will have an opportunity to join one of the leading flavivirus laboratories and work in the dynamic team of internationally recognised experts at the forefront of flavivirus research. He/she will obtain experience in the wide range of classical and modern research techniques such as cryo-electron microscopy, next generation sequencing, generation of mutant viruses, immunofluorescent virus detection, quantitative PCR, Northern blotting, electrophoretic mobility shift assay, etc. He/she will have an opportunity to communicate their research at the national and international conferences and publish in the leading academic journals.

  • Predicting and preparing for the unfolding evolution of SARS-CoV-2

    This Earmarked Scholarship project is aligned with a recently awarded Category 1 research grant. It offers you the opportunity to work with leading researchers and contribute to large projects of national significance.

    SARS-CoV-2 is the cause of current COVID-19 pandemic which has already infected >270 million people and killed >5 million of them. Currently deployed and future vaccines are likely to significantly decrease the burden of pandemic, however, new viral variants are emerging that are less susceptible to vaccine-induced immunity. Hence, deeper understanding of what drives viral evolution under the pressure of vaccine-induced immune responses is needed to predict and prepare for the emergence of future variants and inform development of more effective vaccines. The project will employ deep mutational scanning methodology to identify changes in the viral spike protein responsible for altered susceptibility to vaccine-induced antibodies. The implications of identified changes on the properties of spike protein and susceptibility to vaccine-induced antibodies will be investigated using structural analysis and various functional assays. The findings will be critical for predicting viral changes that are likely to emerge in the landscape of vaccinations and provide invaluable information for pre-emptive development of vaccines that will be able to minimise future emergence of vaccine-resistant variants.

Supervision history

Current supervision

  • Doctor Philosophy

    Predicting and preparing for the unfolding evolution of SARS-CoV-2

    Principal Advisor

    Other advisors: Dr Rhys Parry

  • Doctor Philosophy

    Cooperation between sfRNA and non-structural protein NS5 for flavivirus immune evasion

    Principal Advisor

    Other advisors: Dr Naphak Modhiran, Dr Andrii Slonchak

  • Doctor Philosophy

    Functions of Noncoding Viral RNA in Insect-Specific Flaviviruses

    Associate Advisor

    Other advisors: Dr Andrii Slonchak

  • Doctor Philosophy

    Why certain viruses don't get along in mosquitoes: Dissecting the mechanism of superinfection exclusion

    Associate Advisor

    Other advisors: Dr Andrii Slonchak

  • Doctor Philosophy

    Engineering chimeric viruses as protective and safe vaccines against mosquito-borne viral disease

    Associate Advisor

    Other advisors: Dr Andrii Slonchak, Associate Professor Jody Peters

  • Doctor Philosophy

    Mechanisms of host restriction underpinning the safety and efficacy of novel chimeric flaviviral vaccines

    Associate Advisor

    Other advisors: Associate Professor Jody Peters, Dr Natalee Newton

Completed supervision

Media

Enquiries

Contact Professor Alexander Khromykh directly for media enquiries about:

  • COVID-19
  • Ebola virus
  • Flaviviruses
  • Gene delivery systems
  • Gene expression
  • Immunisation
  • Molecular virology
  • Noncoding RNAs
  • SARS-CoV-2
  • Vaccines
  • Virus-host interactions
  • Viruses
  • West Nile Virus
  • Zika virus

Need help?

For help with finding experts, story ideas and media enquiries, contact our Media team:

communications@uq.edu.au